Dr. Haddad, MD is a Professor of Medicine at Harvard Medical School. He is the McGraw Chair and Division Chief of the Head and Neck Oncology Program, and a member of the Department of Adult Oncology, at Dana-Farber Cancer Institute in Boston. Dr. Haddad’s research is focused on identifying new treatments in head and neck cancer involving the use of induction, concurrent chemotherapy, and radiation therapy for patients with locally advanced head and neck cancer, as well as the development of novel therapeutic agents for treating advanced disease.